Although there is a dearth of literature on the role of epigenetic modifications in the modulation of GPER signaling in diabetic conditions, emerging evidence suggests the involvement of microRNAs in the epigenetic regulation of GPER-mediated estrogen signaling in DM and its vascular complications [46]. The gene discussed is GPER1; the disease is diabetes mellitus.